CAI
Caris Life Sciences, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.21B
P/E Ratio
—
EPS
$-3.22
Beta
—
52W High
$42.50
52W Low
$16.28
50-Day MA
$19.23
200-Day MA
$26.70
Dividend Yield
—
Profit Margin
-8.39%
Forward P/E
34.84
PEG Ratio
—
About Caris Life Sciences, Inc. Common Stock
CAI International, Inc. is a transportation finance company in the United States, Switzerland, France, Korea, Singapore, Rest of Asia, Rest of Europe, and internationally. The company is headquartered in San Francisco, California.
Fundamentals
| Revenue (TTM) | $812.03M |
| Gross Profit (TTM) | $541.04M |
| EBITDA | $67.73M |
| Operating Margin | 30.20% |
| Return on Equity | -45.40% |
| Return on Assets | 3.84% |
| Revenue/Share (TTM) | $4.86 |
| Book Value | $2.04 |
| Price-to-Book | 9.03 |
| Price-to-Sales (TTM) | 6.42 |
| EV/Revenue | 5.96 |
| EV/EBITDA | 425.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 125.40% |
| Shares Outstanding | $282.66M |
| Float | $96.51M |
| % Insiders | 48.53% |
| % Institutions | 51.72% |
Historical Volatility
HV 10-Day
50.77%
HV 20-Day
63.35%
HV 30-Day
61.96%
HV 60-Day
60.93%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($29.69 target)
1
Strong Buy8
Buy1
HoldData last updated: 4/29/2026